0001354457-11-000243.txt : 20111110
0001354457-11-000243.hdr.sgml : 20111110
20111110121358
ACCESSION NUMBER: 0001354457-11-000243
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20111110
DATE AS OF CHANGE: 20111110
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Capstone Therapeutics Corp.
CENTRAL INDEX KEY: 0000887151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 860585310
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33560
BUSINESS ADDRESS:
STREET 1: 1275 WEST WASHINGTON STREET
STREET 2: SUITE 101
CITY: TEMPE
STATE: AZ
ZIP: 85281
BUSINESS PHONE: 6022865520
MAIL ADDRESS:
STREET 1: 1275 WEST WASHINGTON STREET
STREET 2: SUITE 101
CITY: TEMPE
STATE: AZ
ZIP: 85281
FORMER COMPANY:
FORMER CONFORMED NAME: ORTHOLOGIC CORP
DATE OF NAME CHANGE: 19940211
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NASDAQ Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
NASDAQ Stock Market LLC
0000887151
Capstone Therapeutics Corp.
001-33560
1275 West Washington Street, Suite 101
Tempe
AZ
ARIZONA
85281
602-286-5520
Common Stock
17 CFR 240.12d2-2(b)
Amy Horton
Associate General Counsel
2011-11-10
EX-99.25
2
capsdelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
November 10, 2011, Capstone Therapeutics Corp. The Nasdaq Stock
Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Capstone Therapeutics Corp
(the Company), effective at the opening of the trading
session on November 21, 2011. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(a)(2). The Company was
notified of the Staffs determination on May 3, 2011.
The Company appealed the determination to a Hearing Panel.
Upon review of the information provided by the Company,
the Panel issued a decision dated July 11, 2011, granting
the Company continued listing pursuant to an exception
through September 15, 2011, by which date the Company was
required to regain compliance with Listing Rule
5550(a)(2). Subsequently, however, the Company notified the
Panel that it did not intend to take the steps required
to regain compliance by that date. On July 19, 2011,
the Panel issued a final delisting determination and
notified the Company that trading in the Companys
securities would be suspended on July 21, 2011.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company became
final on September 2, 2011.